European journal of clinical pharmacology

Keyphrases

Publications

2023

Laura Kalfsvel, L E J Peeters, K Hoek, Corine Bethlehem, Heleen van der Sijs, Paul-Hugo M van der Kuy, Walter W van den Broek, Jorie Versmissen, Floor van Rosse
Does formative assessment help students to acquire prescribing skills? European journal of clinical pharmacology (2023)
Işıl İrem Budakoğlu, Ozlem Coskun, Yavuz Selim Kıyak, Canan Uluoğlu
Teaching rational prescribing in undergraduate medical education: a systematic search and review. European journal of clinical pharmacology (2023)
Dong Li, Peng Chang, Hongliang Zhang, Feng Bai, Qiang Wu
The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis. European journal of clinical pharmacology (2023)
Birgit M Wollmann, Elisabet Størset, Marianne Kristiansen Kringen, Espen Molden, Robert Løvsletten Smith
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype. European journal of clinical pharmacology (2023)
Ar Kar Aung, Celia M Zubrinich, Michelle S Y Goh, Benjamin Snyder, Mei Jie Tang, Cindy Y L Khu, Jennifer Inhae Lee, Linda Velta Graudins
Development and application of Adverse drug reactions reports QUality Algorithm (AQUA-12) score: a single-centre quality improvement initiative. European journal of clinical pharmacology (2023)
Hye-Jeong Choi, Yonghyuk Lee, Susin Park, Nam Kyung Je
Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. European journal of clinical pharmacology (2023)
Marwah H Barnawi, Abrar K Thabit, Diena M Almasri, Suha Bulbol
Clinical and cost-effectiveness analysis of carbapenems versus ciprofloxacin in the treatment of urinary tract infections due to extended spectrum β-lactamase-producing Enterobacterales. European journal of clinical pharmacology (2023)

volume 79, number 3, 2023

Işıl İrem Budakoğlu, Ozlem Coskun, Yavuz Selim Kıyak, Canan Uluoğlu
Teaching rational prescribing in undergraduate medical education: a systematic search and review. European journal of clinical pharmacology 79 (3) (2023)
Di Fu, Hong-Li Guo, Ya-Hui Hu, Wei-Rong Fang, Qian-Qi Liu, Jing Xu, Dan-Dan Wu, Feng Chen
Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence. European journal of clinical pharmacology 79 (3) (2023)
Takafumi Nakazawa, Shingo Yamazaki, Masashi Uchida, Takaaki Suzuki, Takako Nakamura, Masayuki Ohtsuka, Itsuko Ishii
Relationship between elevated bilirubin levels and enhanced warfarin effects during biliary obstruction. European journal of clinical pharmacology 79 (3) (2023)
Di Fu, Hong-Li Guo, Ya-Hui Hu, Wei-Rong Fang, Qian-Qi Liu, Jing Xu, Dan-Dan Wu, Feng Chen
Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence. European journal of clinical pharmacology 79 (3) (2023)
Yuki Inoue, Yoh Takekuma, Takayuki Miyai, Hitoshi Kashiwagi, Yuki Sato, Mitsuru Sugawara, Shungo Imai
Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopenia. European journal of clinical pharmacology 79 (3) (2023)
Takehiro Miyagi, Daiki Tsuji, Yohei Kawasakai, Hiroshi Ishikawa, Rei Tanaka, Masahiko Nakao, Shigeru Nakagaki, Toshinobu Hayashi, Hideaki Ayuhara, Tomohiko Harada, Shinya Tamaki, Akimitsu Maeda, Yasukata Ohashi, Yuichiro Arakawa, Yukiyoshi Fujita, Keisuke Yamamoto, Yasunori Miyamoto, Takuya Yano, Kunihiko Itoh
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer. European journal of clinical pharmacology 79 (3) (2023)
Işıl İrem Budakoğlu, Ozlem Coskun, Yavuz Selim Kıyak, Canan Uluoğlu
Teaching rational prescribing in undergraduate medical education: a systematic search and review. European journal of clinical pharmacology 79 (3) (2023)
Clémentine Vabre, Kyle Johnson, François Montastruc, Delphine Vezzosi, Oriana H Yu, Christel Renoux
Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase. European journal of clinical pharmacology 79 (3) (2023)
Yuki Inoue, Yoh Takekuma, Takayuki Miyai, Hitoshi Kashiwagi, Yuki Sato, Mitsuru Sugawara, Shungo Imai
Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopenia. European journal of clinical pharmacology 79 (3) (2023)
Ehsan Motaghi, Masoumeh Ghasemi-Pirbaluti, Mohsen Rashidi, Masoud Alasvand, Patricia Di Ciano, Hooman Bozorgi
The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review. European journal of clinical pharmacology 79 (3) (2023)
Di Fu, Hong-Li Guo, Ya-Hui Hu, Wei-Rong Fang, Qian-Qi Liu, Jing Xu, Dan-Dan Wu, Feng Chen
Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence. European journal of clinical pharmacology 79 (3) (2023)
Ye Zhu, Jia You, Xiang Gu, Hua Zhu, Jia Liu
Pharmacogenetics of warfarin dosing in Chinese adults with nonvalvular atrial fibrillation. European journal of clinical pharmacology 79 (3) (2023)
Takehiro Miyagi, Daiki Tsuji, Yohei Kawasakai, Hiroshi Ishikawa, Rei Tanaka, Masahiko Nakao, Shigeru Nakagaki, Toshinobu Hayashi, Hideaki Ayuhara, Tomohiko Harada, Shinya Tamaki, Akimitsu Maeda, Yasukata Ohashi, Yuichiro Arakawa, Yukiyoshi Fujita, Keisuke Yamamoto, Yasunori Miyamoto, Takuya Yano, Kunihiko Itoh
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer. European journal of clinical pharmacology 79 (3) (2023)
Clémentine Vabre, Kyle Johnson, François Montastruc, Delphine Vezzosi, Oriana H Yu, Christel Renoux
Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase. European journal of clinical pharmacology 79 (3) (2023)
Takehiro Miyagi, Daiki Tsuji, Yohei Kawasakai, Hiroshi Ishikawa, Rei Tanaka, Masahiko Nakao, Shigeru Nakagaki, Toshinobu Hayashi, Hideaki Ayuhara, Tomohiko Harada, Shinya Tamaki, Akimitsu Maeda, Yasukata Ohashi, Yuichiro Arakawa, Yukiyoshi Fujita, Keisuke Yamamoto, Yasunori Miyamoto, Takuya Yano, Kunihiko Itoh
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer. European journal of clinical pharmacology 79 (3) (2023)
Marwah H Barnawi, Abrar K Thabit, Diena M Almasri, Suha Bulbol
Clinical and cost-effectiveness analysis of carbapenems versus ciprofloxacin in the treatment of urinary tract infections due to extended spectrum β-lactamase-producing Enterobacterales. European journal of clinical pharmacology 79 (3) (2023)
Ehsan Motaghi, Masoumeh Ghasemi-Pirbaluti, Mohsen Rashidi, Masoud Alasvand, Patricia Di Ciano, Hooman Bozorgi
The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review. European journal of clinical pharmacology 79 (3) (2023)
Ehsan Motaghi, Masoumeh Ghasemi-Pirbaluti, Mohsen Rashidi, Masoud Alasvand, Patricia Di Ciano, Hooman Bozorgi
The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review. European journal of clinical pharmacology 79 (3) (2023)
Ye Zhu, Jia You, Xiang Gu, Hua Zhu, Jia Liu
Pharmacogenetics of warfarin dosing in Chinese adults with nonvalvular atrial fibrillation. European journal of clinical pharmacology 79 (3) (2023)
Marwah H Barnawi, Abrar K Thabit, Diena M Almasri, Suha Bulbol
Clinical and cost-effectiveness analysis of carbapenems versus ciprofloxacin in the treatment of urinary tract infections due to extended spectrum β-lactamase-producing Enterobacterales. European journal of clinical pharmacology 79 (3) (2023)
Takafumi Nakazawa, Shingo Yamazaki, Masashi Uchida, Takaaki Suzuki, Takako Nakamura, Masayuki Ohtsuka, Itsuko Ishii
Relationship between elevated bilirubin levels and enhanced warfarin effects during biliary obstruction. European journal of clinical pharmacology 79 (3) (2023)
Marwah H Barnawi, Abrar K Thabit, Diena M Almasri, Suha Bulbol
Clinical and cost-effectiveness analysis of carbapenems versus ciprofloxacin in the treatment of urinary tract infections due to extended spectrum β-lactamase-producing Enterobacterales. European journal of clinical pharmacology 79 (3) (2023)
Clémentine Vabre, Kyle Johnson, François Montastruc, Delphine Vezzosi, Oriana H Yu, Christel Renoux
Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase. European journal of clinical pharmacology 79 (3) (2023)
Ye Zhu, Jia You, Xiang Gu, Hua Zhu, Jia Liu
Pharmacogenetics of warfarin dosing in Chinese adults with nonvalvular atrial fibrillation. European journal of clinical pharmacology 79 (3) (2023)
Işıl İrem Budakoğlu, Ozlem Coskun, Yavuz Selim Kıyak, Canan Uluoğlu
Teaching rational prescribing in undergraduate medical education: a systematic search and review. European journal of clinical pharmacology 79 (3) (2023)
Yuki Inoue, Yoh Takekuma, Takayuki Miyai, Hitoshi Kashiwagi, Yuki Sato, Mitsuru Sugawara, Shungo Imai
Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopenia. European journal of clinical pharmacology 79 (3) (2023)
Takafumi Nakazawa, Shingo Yamazaki, Masashi Uchida, Takaaki Suzuki, Takako Nakamura, Masayuki Ohtsuka, Itsuko Ishii
Relationship between elevated bilirubin levels and enhanced warfarin effects during biliary obstruction. European journal of clinical pharmacology 79 (3) (2023)

volume 79, number 4, 2023

Rafael Dal-Ré
Waivers of informed consent in research with competent participants and the Declaration of Helsinki. European journal of clinical pharmacology 79 (4) (2023)
Rafael Dal-Ré
Waivers of informed consent in research with competent participants and the Declaration of Helsinki. European journal of clinical pharmacology 79 (4) (2023)
Satoshi Tanizaki, Kinnosuke Matsumoto, Akihiro Tamiya, Yoshihiko Taniguchi, Yoshinobu Matsuda, Junji Uchida, Kiyonobu Ueno, Hayato Kawachi, Motohiro Tamiya, Takafumi Yanase, Hidekazu Suzuki, Kyoichi Okishio
Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study. European journal of clinical pharmacology 79 (4) (2023)
Gianluca Gazzaniga, Danilo Menichelli, Francesco Scaglione, Alessio Farcomeni, Arianna Pani, Daniele Pastori
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses. European journal of clinical pharmacology 79 (4) (2023)
Birgit M Wollmann, Elisabet Størset, Marianne Kristiansen Kringen, Espen Molden, Robert Løvsletten Smith
Prediction of CYP2D6 poor metabolizers by measurements of solanidine and metabolites-a study in 839 patients with known CYP2D6 genotype. European journal of clinical pharmacology 79 (4) (2023)
Hye-Jeong Choi, Yonghyuk Lee, Susin Park, Nam Kyung Je
Utilization of triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. European journal of clinical pharmacology 79 (4) (2023)
Adriana F S Fontes, Fernando M Reis, Ana Lúcia Cândido, Karina Braga Gomes, Jéssica A G Tosatti
Influence of metformin on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized clinical trials. European journal of clinical pharmacology 79 (4) (2023)
Ar Kar Aung, Celia M Zubrinich, Michelle S Y Goh, Benjamin Snyder, Mei Jie Tang, Cindy Y L Khu, Jennifer Inhae Lee, Linda Velta Graudins
Development and application of Adverse drug reactions reports QUality Algorithm (AQUA-12) score: a single-centre quality improvement initiative. European journal of clinical pharmacology 79 (4) (2023)
Laura Kalfsvel, L E J Peeters, K Hoek, Corine Bethlehem, Heleen van der Sijs, Paul-Hugo M van der Kuy, Walter W van den Broek, Jorie Versmissen, Floor van Rosse
Does formative assessment help students to acquire prescribing skills? European journal of clinical pharmacology 79 (4) (2023)
Xiwen Qin, Joseph Hung, Matthew W Knuiman, Tom G Briffa, Tiew-Hwa Katherine Teng, Frank M Sanfilippo
Evidence-based medication adherence among seniors in the first year after heart failure hospitalisation and subsequent long-term outcomes: a restricted cubic spline analysis of adherence-outcome relationships. European journal of clinical pharmacology 79 (4) (2023)
Jean-Louis Montastruc
Safety of pitolisant: a study in the WHO international pharmacovigilance database. European journal of clinical pharmacology 79 (4) (2023)
K R Doornhof, P D van der Linden, G M Boeke, A E C A B Willemsen, A Daskapan
Dihydropyrimidine dehydrogenase phenotype in peripheral blood mononuclear cells is related to adverse events of fluoropyrimidine-therapy. European journal of clinical pharmacology 79 (4) (2023)
Laura Kalfsvel, L E J Peeters, K Hoek, Corine Bethlehem, Heleen van der Sijs, Paul-Hugo M van der Kuy, Walter W van den Broek, Jorie Versmissen, Floor van Rosse
Does formative assessment help students to acquire prescribing skills? European journal of clinical pharmacology 79 (4) (2023)
Michiel J Bakkum, Erik M Donker, Pietro Spitaleri Timpone, Charlotte A M Hagen, Milan C Richir, Michiel A van Agtmael, Fabrizio De Ponti, Jelle Tichelaar, null null
Educational value of international and intercultural differences in prescribing: the international and interprofessional student-run clinic project. European journal of clinical pharmacology 79 (4) (2023)
Dong Li, Peng Chang, Hongliang Zhang, Feng Bai, Qiang Wu
The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis. European journal of clinical pharmacology 79 (4) (2023)
Mehmet Zahid Koçak, Muhiddin Er, Muzaffer Ugrakli, Engin Hendem, Murat Araz, Melek Karakurt Eryilmaz, Mehmet Artac
Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer? European journal of clinical pharmacology 79 (4) (2023)